RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

STOCKHOLM (AP) — The Nobel prizes award season begins Monday with the announcement by a panel at the Karolinska Institute in ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...

The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

According to GlobalData, while the majority of the 22 vaccine candidates currently in development rely on traditional ...

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...

Penn Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary ...